Form 4: Neuronetics EVP Macan Gains 33,750 Shares

Neuronetics, Inc.'s EVP, CLO, and CS, William Andrew Macan, acquired 33,750 shares of common stock for no consideration through a performance-based restricted stock unit award.

Summary

• William Andrew Macan, Executive Vice President, Chief Legal Officer, and Corporate Secretary of Neuronetics, Inc. (STIM), acquired 33,750 shares of common stock.
• The shares were received for no consideration ($0 price) on March 17, 2026.
• This acquisition resulted from the satisfaction of performance criteria underlying an award of performance-based restricted stock units.
• Following this transaction, Macan beneficially owns a total of 913,275 shares of Neuronetics common stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan, indicating it was a pre-planned acquisition.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event, reflecting the successful achievement of performance targets by a key executive and increasing insider ownership, which generally aligns management incentives with shareholder value.

Positives

• A key executive received a significant number of shares (33,750) as a reward for meeting performance criteria, which suggests successful achievement of company goals.
• Increased insider ownership aligns management's interests more closely with those of shareholders, potentially fostering long-term value creation.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that executive compensation tied to performance criteria, as seen in this RSU vesting, is a common practice across the medical device and healthcare technology sectors. It aims to incentivize long-term value creation and align management's interests with shareholder returns, a standard approach for companies like Neuronetics operating in competitive markets.

Stakeholder Impact

• Shareholders: Potentially positive as it indicates that performance targets were met, which could reflect positively on company operations, and increases insider alignment with shareholder interests.
• Employees: May signal a healthy and effective executive compensation structure tied to performance, which can be a positive for overall employee morale and retention.

Key Dates

Recommendation

This Form 4 filing details a routine, pre-planned executive compensation event where performance-based restricted stock units vested. While it indicates that performance criteria were met and increases insider ownership, it does not provide new fundamental information about the company's operational or financial health that would warrant a change in investment recommendation. It's an expected outcome of an existing compensation plan.

Keywords

Neuronetics, STIM, Insider Trading, Form 4, Restricted Stock Units, Performance Award, Executive Compensation, William Andrew Macan, Stock Acquisition